cardiomyopathy

Silhouette of Businessman Entering Lit Door Passage in Darkness
Biotech

Cytokinetics doesn't want Big Pharma help to overtake Camzyos

For a biotech planning to commercialize its first drug—and without Big Pharma backing—the company's CEO Robert Blum is keeping his cool.
James Waldron Nov 18, 2025 1:30pm
FDA stop sign

FDA puts Tenaya heart disease gene therapy trial on hold

Nov 10, 2025 5:16am
Shield soldier knight armour sword

Braveheart, with Biogen CEO on board, rallies $185M series A

Nov 5, 2025 7:51am
heart money

Cytokinetics’ ph. 3 cardio win sends stock soaring

Sep 2, 2025 2:05pm
Rocket with heart on blue background

Rocket's gene therapy sets new efficacy bar in ph. 1 heart study

May 16, 2025 10:36am
valentines day fail

Edgewise claims heart pressure reductions for Camzyos rival

Apr 2, 2025 8:45am